These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20089696)
1. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696 [TBL] [Abstract][Full Text] [Related]
2. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model. Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner. Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387 [TBL] [Abstract][Full Text] [Related]
4. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies. Nishie W; Sawamura D; Natsuga K; Shinkuma S; Goto M; Shibaki A; Ujiie H; Olasz E; Yancey KB; Shimizu H J Immunol; 2009 Sep; 183(6):4088-93. PubMed ID: 19717520 [TBL] [Abstract][Full Text] [Related]
5. Humanization of autoantigen. Nishie W; Sawamura D; Goto M; Ito K; Shibaki A; McMillan JR; Sakai K; Nakamura H; Olasz E; Yancey KB; Akiyama M; Shimizu H Nat Med; 2007 Mar; 13(3):378-83. PubMed ID: 17322897 [TBL] [Abstract][Full Text] [Related]
6. What's new in bullous pemphigoid. Ujiie H; Shibaki A; Nishie W; Shimizu H J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382 [TBL] [Abstract][Full Text] [Related]
8. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models. Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H Front Immunol; 2019; 10():1410. PubMed ID: 31275329 [TBL] [Abstract][Full Text] [Related]
9. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619 [TBL] [Abstract][Full Text] [Related]
10. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model. Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of bullous pemphigoid. Ujiie H; Nishie W; Shimizu H Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134 [TBL] [Abstract][Full Text] [Related]
12. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid. Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201 [TBL] [Abstract][Full Text] [Related]
13. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541 [TBL] [Abstract][Full Text] [Related]
14. [Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"]. Nishie W; Shimizu H Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):472-7. PubMed ID: 20046014 [TBL] [Abstract][Full Text] [Related]
15. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2. Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E Front Immunol; 2018; 9():488. PubMed ID: 29599777 [TBL] [Abstract][Full Text] [Related]
16. Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Schulze FS; Beckmann T; Nimmerjahn F; Ishiko A; Collin M; Köhl J; Goletz S; Zillikens D; Ludwig R; Schmidt E Am J Pathol; 2014 Aug; 184(8):2185-96. PubMed ID: 25043618 [TBL] [Abstract][Full Text] [Related]
17. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Leighty L; Li N; Diaz LA; Liu Z Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094 [TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone. Xu L; Olivry T; Chan LS Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950 [TBL] [Abstract][Full Text] [Related]
19. Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180. Wada M; Nishie W; Ujiie H; Izumi K; Iwata H; Natsuga K; Nakamura H; Kitagawa Y; Shimizu H J Invest Dermatol; 2016 May; 136(5):938-946. PubMed ID: 26827765 [TBL] [Abstract][Full Text] [Related]
20. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies. Nishie W Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]